The U.S. House passed Right to Try legislation on Tuesday that gives the terminally ill access to experimental drugs showing efficacy in clinical trials but not yet approved by the FDA.
The bill now awaits President Donald Trump's signature and he has indicated he will sign it.
The House passed the legislation by a vote of 250-169, largely along party lines, though 22 Democrats voted with Republicans to pass the bill. All the no votes were Democrats.
"This legislation, introduced only last week, is an egregious attempt by a libertarian think tank to undermine the ‘gold standard' drug approval process at the Food and Drug Administration," said Rep. Frank Pallone (D., NJ) on the House floor.
More here
DelMarVa's Premier Source for News, Opinion, Analysis, and Human Interest Contact Publisher Joe Albero at alberobutzo@wmconnect.com or 410-430-5349
2 comments:
Old way of thinking/doing business is gradually making an exit! Just wish City Hall in OC would just starting THINKING!
Just don't expect to sue the drug manufacturer when the medication doesn't work or hastens your demise.
Post a Comment